期刊文献+

无细胞百日咳疫苗生产用菌株CS的5种保护性抗原基因序列分析 被引量:1

Gene Sequencing of Five Kinds of Protective Antigens of CS Strain for Production of Acellular Pertussis Vaccine
原文传递
导出
摘要 目的对我国无细胞百日咳疫苗生产用菌株CS的5种保护性抗原的基因序列进行分析。方法分别用PCR扩增CS菌株的PT、FHA、PRN、FIM2和FIM3基因,克隆至pGEM-TEasy vector中,进行序列测定及分析,并确定其基因型。结果获得了CS菌株PT、FHA、PRN、FIM2和FIM35段基因克隆,其核苷酸和氨基酸序列与GenBank中收录的相应百日咳杆菌的同源性均在90%以上,种系进化树分析结果与鲍特菌属进化结果一致。CS的基因型为:PTS1属于ptxS1B型,PTS3属于ptxS3A型,FHA属于FHA1型,PRN属于PRN1型,FIM2属于FIM2-1型,FIM3属于FIM3A型。结论本研究为更好地对我国无细胞百日咳疫苗进行质量控制和百日咳杆菌的基因漂移研究奠定了基础。 Objective To analyze the gene sequences of five kinds of protective antigens of CS strain for production of acellular pertnssis vaccine in China. Methods The PT, FHA, PRN, FIM2 and FIM3 genes of CS strain were amplified by PCR and cloned into pGEM-T Easy vector for gcne sequencing, based on which the genotypes were determined. Results The PT, FHA, PRN, FIM2 and FIM3 gene clones were obtained, of which the homologies of nucleotide and amino acid sequences were more than 90% to, and the results of analysis by phylogenetic tree were consistent with those of Bordetella pertussis reported in GenBank. The PT S1, PTS3, FHA, PRN, FIM2 and FIM3 of CS strain were of genotypes of ptXS1B, ptxS3A, FHA1, PRN1, FIM2-1 and FIM3A respectively. Conclusion The gene sequences of five kinds of protective antigens of CS strain were analyzed, which laid a foundation of further quality control of acellular pertussis vaccine in China and study on the gene drift of Bordetella pertussis.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第3期259-262,共4页 Chinese Journal of Biologicals
关键词 无细胞百日咳疫苗 CS菌株 保护性抗原 基因序列 Accllular pertussis vaccine CS strain Protective antigen Gene sequence
  • 相关文献

参考文献9

  • 1Mastrantonio P, Spiqaqlia P, Van Oirschot H, et al. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology, 1999, 145 ( Pt 8): 2069-2075.
  • 2Packard ER, Parton R, Coote JG, et al. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol, 2004, 53(Pt 5): 355-365.
  • 3Mooi FR, Van Loo IHM, King AJ. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence. Emerg Infect Dis, 2001, 7 (3 Suppl): 526-528.
  • 4Mooi FR, Van Oirschot H, Heurelman K, et al. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun, 1998, 66(2): 670-675.
  • 5Van Loo IHM, Heuvelman KJ, King AJ, et al. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol, 2002, 40(6): 1994-2001.
  • 6Fry NK, Neal S, Harrison TG, et al. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun, 2001, 69(9): 5520-5528.
  • 7Zhang JM, Cowell JL, Steven AC, et al. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. Dev Biol Stand, 1985, 61: 173-185.
  • 8Tsang RSW, Lau AKH, Sill ML, et al. Polymorphisms of the fimbria tim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol, 2004, 42( 11 ): 5364-5367.
  • 9Van Loo IHM, Van Der Heide HGT, Nagelkerke N J, et al. Temporod trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J Infect Dis, 1999, 179: 915-923.

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部